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The present study was to evaluate the survival rate of free and encapsulated Bifi dobacterium bifi dum BB28 under 
simulated gastrointestinal conditions and its stability during storage. Results showed that non-microencapsulated 
Bifi dobacterium bifi dum BB28 was more susceptible to simulated gastrointestinal conditions than microencapsulated 
bacteria. Microencapsulated Bifi dobacterium BB28 exhibited a lower population reduction than free cells during 
exposure to simulated gastrointestinal conditions, the viable count of monolayer microcapsules, double layer 
microcapsules, and triple layer microcapsules decreased by nine magnitudes, four magnitudes, and one magnitude 
after 2 h, respectively. The enteric test showed that the microorganism cells were released from the monolayer, 
double layer, and triple layer microcapsules completely in 40 min. Moreover, the optimum storage times of free 
Bifi dobacterium BB28, monolayer microcapsules, double layer microcapsules, and triple layer microcapsules were 
21 days, 21 days, 28 days, and more than 35 days in orange juice, pure milk, and nutrition Express (a commercially 
available milk based drink), and the viable counts were maintained at 1×106 CFU g–1 or more, which means that the 
double layer and triple layer of microcapsules of B. bifi dum BB28 have great potential in food application.
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Probiotics are living microorganisms, which are benefi cial to human health (FAO/WHO, 
2002). Lactobacilli and bifi dobacteria species have shown benefi cial effects on 
immunomodulation and on susceptibility to various intestinal diseases (SHAH. 2007; DENKOVA 
et al., 2011). However, these probiotics are also fastidious and obligate anaerobes, which 
pose a technological challenge for the dairy industry. To utilize their benefi cial properties, 
probiotics must be able to tolerate the acidic conditions in the stomach environment as well 
as bile in the small intestine (DOLEYRES et al., 2004). The acidic environment in the stomach 
and bile salts secreted into the duodenum are the main obstacles to the survival of the ingested 
bacteria. In general, bifi dobacteria have a relatively lower tolerance for the pH of the gastric 
juice (COLLADO & SANZ, 2006). Moreover, the survival rate of probiotics during processing 
and storage of food is also essential for the development of products that have an adequate 
number of viable cells (ANAL & SINGH, 2007). The benefi ts promoted by probiotic bacteria are 
increasingly explored in different uses in various types of foods (SOUZA & SAAD, 2009). 
Nowadays, the application of non-milk-based probiotic preparations used to obtain beverages 
or directly as probiotic tablets, capsules, or lyophilized preparations increases (DENKOVA et 
al., 2014).
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Microencapsulation is a promising technique to render physical protection and improve 
the stability of probiotic organisms in functional food products (GOUIN, 2004; ANAL & SINGH, 
2007; BRINQUES & MAZ, 2011). However, results showed that the survival rate of probiotics 
after exposure to acid are rarely satisfactory, and when a high protection against gastric juice 
was noted, the survival of the cells dramatically decreased within a few weeks during storage 
(ALBERTINI et al., 2010).
The aim of this paper is to evaluate the survival rate of Ca-alginate microencapsulated 
Bifi dobacterium bifi dum BB28 (B. bifi dum BB28) in artifi cially simulated gastric juices, bile 
salt, and intestinal tract, and to study the stability of microencapsulation of B. bifi dum BB28 
in food.
1. Materials and methods
1.1. Materials
The strain of B. bifi dum BB28 was obtained from School of Food & Biology Engineering, 
Shaanxi University of Science & Technology. Alginate (Luo Senbo Technology Co., Ltd. 
Xi’an), was used as carrier agent and MRS broth (Hope Bio-Technology Co., Ltd. Qingdao) 
as cultivation medium. All chemicals used were of analytical grade. Centrifuge (LG10-2.4) 
was used to obtain microcapsules.
1.2. Microorganism
B. bifi dum BB28 was cultured for 24 h in MRS medium at 37 °C, the cells were harvested by 
centrifugation at 1500×g for 10 min at 4 ºC, and washed twice before suspending them in 5 
ml normal saline. The fi nal cell concentration was adjusted to 1.0×1011 CFU ml–1.
1.3. Microencapsulation
B. bifi dum BB28 was encapsulated in sodium alginate matrix. Sodium alginate solutions (2% 
w/v) and chitosan solution (1% w/v, pH 5.3) were prepared, sterilized by autoclaving (120 ºC 
for 15 min) and cooled to 38–40 ºC. Palm oil (food grade) was prepared, melted for 15 min 
at 37 ºC. 2% sodium alginate solutions (10 ml) and 1 ml of free cell suspension were 
transferred into a centrifuge tube, and the content was vortexed to homogeneity. The alginate–
cell mixture was added dropwise to a beaker (300 ml) containing an emulsion of oil and 
water in ratio 5:1, containing 0.4% Tween 80, while stirring magnetically. After 15 min, a 
uniformly turbid emulsion was obtained where 2% calcium chloride was quickly added to 
harden microcapsules and break the emulsion. The monolayer microcapsules (MM) were 
harvested by centrifugation at 1500×g for 10 min. To form chitosan coated sodium alginate 
double layer microcapsules (DM), 1% chitosan solution was added and mixed with the 
above-mentioned monolayer microcapsules for 30 min, and washed with sterile saline 
solution for three times. Finally, the palm oil coated sodium alginate-chitosan beads were 
formed b y adding palm oil, mixing for 30 min, and washing with sterile saline solution for 
three times. Thus, free B. bifi dum BB28, alginate sodium encapsulated B. bifi dum BB28 cells 
(MM), alginate-chitosan encapsulate B. bifi dum BB28 (DM), and alginate-chitosan-palm oil 
encapsulate B. bifi dum BB28 (TM) were obtained for further evaluation of survival and 
storage stability.
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1.4. Viable count
The 1 g capsules were transferred into test tubes containing 9 ml tri-sodium citrate to free the 
encapsulated bacteria. The samples were diluted tenfold by sterile saline solution, and the 
appropriate dilutions were transferred to anaerobic tubes containing MRS agar, then incubated 
at 37 ºC for 48 h. The method for counting viable bacteria was described by CHEN and co-
workers (2012).
1.5.  Survival of microencapsulated and non-microencapsulated B. bifi dum BB28 under 
simulated gastrointestinal conditions
1.5.1. Gastric juice tolerance test. The simulation of gastric juice conditions was done in HP 
medium (0.16% hydrogen chloride, 0.1% pepsin) with pH adjusted to 1.2. One gram of 
microcapsules or 1.0 ml of free suspended cells was added to test tubes containing 9 ml of HP 
medium. The tubes were incubated at 37 °C and samples were collected in triplicate at 0 h, 
1 h, and 2 h. The viable counts of the free and encapsulated B. bifi dum BB28 were evaluated 
as described in Section 1.4.
1.5.2. Bile salt tolerance test. To determine the resistance to bile salts, 1 ml of free and 
1 g of encapsulated cells were transferred to 9 ml solution containing 1% bile salts. Triplicate 
samples were collected after incubation at 37 °C for 0 h, 1 h, and 2 h. Cell counts of the free 
and encapsulated bacteria were enumerated as described in Section 1.4.
1.5.3. Simulated intestinal fl uid test. To evaluate the release time of microencapsulated 
cells in simulated intestinal fl uid, microcapsules (1 g) were added to test tubes containing 
9 ml pre-warmed 37 °C simulated intestinal fl uid (1.38% potassium dihydrogen phosphate, 
0.4% sodium hydroxide, and 1% pancreatic enzymes), and samples in triplicate were taken 
after incubation at 37 °C for 0 h, 1 h, and 2 h. The viable counts were enumerated as described 
in Section 1. 4.
1.6.  Evaluation of the stability of microencapsulated B. bifi dum BB28 in juice, nutrition 
Express, and pure milk
One g of microcapsulated B. bifi dum BB28 was added to 9 ml of orange juice, nutrition 
Express, and pure milk, and then the viable count, pH, and acidity were measured every 
7 days while storage at 4 ºC and room temperature. Also, the control group experiments were 
performed by adding B. bifi dum BB28 free cell suspension to orange juice, nutrition Express, 
and pure milk.
1.7. Determination of pH
The acidity meter PHs-3c was used to determine the pH at room temperature (HE et al., 2011; 
SHU et al., 2012).
1.8. Determination of acidity
The determination of acidity was performed according to DENKOVA and co-workers (2012).
Acta Alimentaria 47, 2018
29SHU et al.: IN VITRO TEST OF SURVIVAL OF B. BIFIDUM
2. Results and discussion
2.1. Survival of B. bifi dum BB28 in simulated gastrointestinal conditions
2.1.1. Gastric juice tolerance test. As seen from Table 1, there was a signifi cant decrease in 
the viability of free B. bifi dum BB28 cells and monolayer microcapsules compared to double 
layer and triple layer microcapsules under simulated acidic condition s. The viable counts of 
free B. bifi dum BB28 and monolayer microcapsules in 2 h decreased to 0. For the other two 
samples the protection provided by the chitosan was due to strong bonding between chitosan 
and alginate by electrostatic interactions, leading to formation of a membrane on the surface 
of the granules. Similar results were obtained by ANNAN and co-workers (2008), which 
illustrated double and triple layer Bifi dobacterium microcapsules had a better stability and 
stronger resistance to acid. On the other hand, SUN and GRIFFITHS (2000) found that the viable 
count of free Bifi dobacterium decreased from 1.233×109 CFU ml–1 to an undetectable level in 
30 min, however, the viable count of immobilized cells in gellan–xanthan beads decreased by 
only 0.67 log cycle in the same time interval, and 6.3×105 CFU ml–1 remained after 120 min, 
which suggested that immobilization protected further Bifi dobacterium from the extreme 
acid environment in the human stomach. The microencapsulation effi ciency for monolayer, 
double layer, and triple layer microcapsules were 88.24%, 89.24%, and 100% in present 
experiment, respectively.
Table 1. Viability of microencapsulated and non-microencapsulated B. bifi dum BB28 under simulated acidic 
conditions (CFU g–1)
Samples 0 1 h 2 h
FS 4.41×109 1.09×103 0
MM 2.14×109 6.23×104 0
DM 1.97×109 3.92×107 5.79×105
TM 1.97×109 1.02×109 5.36×108
FS: free cell suspension; MM: monolayer microcapsules; DM: double layer microcapsules; TM: triple layer 
microcapsules
2.1.2. Bile salt tolerance test. Table 2 shows that the viable count of free B. bifi dum 
BB28 and monolayer microcapsules decreased to 0 after 2 h, but the viable count of double 
layer and triple layer microcapsules were 6.89×105 CFU ml–1 and 5.92×108 CFU ml–1, 
respectively. The mall materials used for microencapsulation were chitosan and palm oil, 
which improved the viability of B. bifi dum BB28. Similar results were obtained by CHÁVARRI 
and co-workers (2010).
Prebiotics can promote the growth of probiotics in microcapsules. Previous research 
indicated that chitosan coating could protect microcapsules in bile salt solution due to an ion 
exchange reaction (SHI et al., 2013a; b). In addition, SOHAIL and co-workers (2011) found that 
the survival rate of probiotics was highly dependent on the species microencapsulated. 
CASTRO-CISLAGHI and co-workers (2012) found that microencapsulation with whey failed to 
prote ct probiotic cells, but in the current study, when using sodium alginate, chitosan, and 
palm oil to protect probiotic cells, the results showed that the survival rate of encapsulated B. 
bifi dum BB28 was satisfactory in bile.
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Table 2. Viability of microencapsulated and non-microencapsulated B. bifi dum BB28 under simulated bile 
conditions (CFU g–1)
Samples 0 1 h 2 h
FS 4.41×109 2.01×103 0
MM 2.14×109 0.93×105 0
DM 1.97×109 3.78×107 6.89×105
TM 1.97×109 1.12×109 5.92×108
FS: free cell suspension; MM: monolayer microcapsules; DM: double layer microcapsules; TM: triple layer 
microcapsules
2.1.3. In vitro enteric test. Table 3 shows the viability of microencapsulated B. bifi dum 
BB28 released under simulated enteric tract conditions. It can be seen that the viable count 
reached the maximum when the microcapsules were treated for 40 min, however, the number 
of living bacteria showed a downward trend after that. The enteric test showed the 
microorganism cells were released from the monolayer, double layer, and triple layer 
microcapsules completely in 40 min, so the method by microencapsulating to protect 
probiotics was effective. Moreover, MARTONI and co-workers (2007) verifi ed an increase in 
viability of 0.9–1.0 log CFU ml–1 when L. plantarum 80 BSH+ strain was exposed to 
simulated intestinal conditions for a 10 h incubation time.
Table 3. Viability of microencapsulated B. bifi dum BB28 released under simulated enteric tract conditions 
(CFU g–1)
Samples 20 min 40 min 60 min
MM 1.90×107 2.14×109 1.90×109
DM 3.83×106 1.97×109 1.09×109
TM 1.12×106 1.97×109 1.81×109
MM: monolayer microcapsules; DM: double layer microcapsules; TM: triple layer microcapsules
2.2. The stability for the microcapsules of B. bifi dum BB28 in orange juice, nutrition 
Express, and pure milk. Figures 1 to 2 show the stability of free B. bifi dum BB28, monolayer 
microcapsules, double layer microcapsules, and triple layer microcapsules in orange juice 
and nutrition Express. It can be seen from the fi gures that the viable counts of B. bifi dum 
BB28 under 4 ºC and room temperature decreased in the following order: free cells, monolayer 
microcapsules, double layer microcapsules, and triple layer microcapsules. The main reason 
for the decrease in the number of viable bacteria was the acidic environm ent in orange juice 
and nutrition Express, which could inhibit or even kill some of the bacteria, but the viable 
count was maintained at 1×106 CFU g–1 or more, for double layer and triple layer microcapsules 
after 28 days. Figure 3 shows that the viable counts of free B. bifi dum BB28, monolayer 
microcapsules, double layer microcapsules, and triple layer microcapsules remained 
1010 CFU g–1 in pure milk at 4 ºC, but the viable count increased to 1012 CFU g–1 at room 
temperature, the reason for this phenomenon were that the temperature promoted the growth 
and reproduction of the bacteria, what’s more, the pH value of pure milk was close to neutral,
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Fig. 1. The viable cell count, acidity, and pH of B. bifi dum BB28 in fruit orange stored at 4 °C (A, B, C) and room 
temperature (D, E, F) (FS: free cell suspension; MM: monolayer microcapsules; DM: double layer microcapsules; 
TM: triple layer microcapsules)
: FS; : MM; : DM; : TM
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Fig. 2. The viable cell count, acidity, and pH of B. bifi dum BB28 in nutrition Express stored at 4 °C (A, B, C) 
and room temperature (D, E, F) (FS: free cell suspension; MM: monolayer microcapsules; DM: double layer 
microcapsules; TM: triple layer microcapsules)
: FS; : MM; : DM; : TM
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Fig. 3. The viable cell count, acidity, and pH of B. bifi dum BB28 in pure milk stored at 4 °C (A, B, C) and room 
temperature (D, E, F) (FS: free cell suspension; MM: monolayer microcapsules; DM: double layer microcapsules; 
TM: triple layer microcapsules)
: FS; : MM; : DM; : TM
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which was suitable for the preservation of B. bifi dum BB28. It can be concluded from the 
fi gures that the optimum storage times of free B. bifi dum BB28, monolayer microcapsules, 
double microcapsules, and triple layer microcapsules were 21 days, 21 days, 28 days, more 
than 35 days; and 7 days, 14 days, 21 days and 28 days at 4 ºC and room temperature, 
respectively. Nevertheless, GROSS and FÁVARO-TRINDADE (2004) found the number of viable 
cells of immobilized B. lactis in yoghurt presented a gradual decline during the whole storage 
period, passing from 108 CFU ml–1 to no count after 28 days of storage, the reasons for this 
phenomenon were inhibitory substances produced by the yoghurt culture or an excess of 
dissolved oxygen. But MATIAS and co-workers (2016) found the populations of Bifi dobacterium 
Bb-12 were slightly exceeding 6 log CFU g–1 in ice cream with oligofructose at 90 days of 
storage; meanwhile the viability of B. animalis Bb-12 in all synbiotic apple ice cream 
formulations tested was satisfactory until the 84th day of frozen storage, with populations of 
around 7.5 to 8.5 log CFU g–1.
3. Conclusions
In this study, acid and bile salt resistance results showed that the viable count of free B. 
bifi dum BB28 decreased to 0 after 2 hours in simulated bile salt and gastric juice, and the 
viable counts of monolayer, double layer, and triple layer microcapsules decreased by nine 
magnitudes, four magnitudes and one magnitude, respectively. The enteric test showed that 
the microorganism cells were released completely from the microcapsules under simulated 
intestinal fl uid in 40 min, which demonstrated the applicability of microcapsules of B. bifi dum 
BB28 in food. In addition, the optimum storage times, maintaining 1×106 CFU g–1 or more, 
of free B. bifi dum BB28, monolayer microcapsules, double layer microcapsules, and triple 
layer microcapsules were 21 days, 21 days, 28 days, and more than 35 days, respectively, at 
4 °C; and 7 days, 14 days, 21 days, and more than 28 days, respectively, at room temperature 
overall in orange juice, pure milk, and nutrition Express. The experimental results showed 
th at the double layer and the triple layer microcapsules of B. bifi dum BB28 had great 
application possibilities in food.
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